VARIAN VIS/200 ANIMAL IMAGER/SPECTROSCOPY SYSTEM

克利夫兰诊所是第一家采用 MR成像作为其常规诊断方法之一， 在乎 基金会一直处于领先地位， 临床MRI，目前正在探索体内多核MRS 用于临床诊断和预后。 为了建立 使用新的核尺寸的临床理由 磁共振（NMR），许多研究项目使用动物 PHS鼓励和支持的模式。 当前 总共有10多个PHS支持（直接或间接） 涉及利用体内MR成像的项目， 谱 这些项目包括肾脏、心脏和 脑血管和肿瘤 当然需要一个共同的 动物单位，以扩大各种体内研究 生物医学项目。 拟议的瓦里安维斯/200系统将 扩展我们在MRS和MRI方面的能力，不仅通过 更高的灵敏度和更高的空间分辨率， 新光谱技术的应用和测试， 成像序列。 该系统将有助于我们制定一个 继续为生物医学做出贡献。

The Cleveland Clinic is one of the first hospitals to employ the MR imaging as one of its routine diagnostic modalities in patient care. The Foundation has always been in a leading position in clinical MRI and is currently exploring multi-nuclei in vivo MRS for clinical diagnosis and prognosis. In order to establish the clinical justifications for utilizing the new dimensions of nuclear magnetic resonance (NMR), many research projects using animal models are encouraged and supported by PHS. Currently there are a total of more than 10 PHS supported (directly or indirectly) projects involving with utilizing in vivo MR imaging and spectroscopy. The projects include organs of kidney, heart and brain, vessels and tumors. There is certainly a need for a shared animal unit to permit expansion of in vivo studies of various biomedical projects. The proposed Varian VIS/200 system would expand our capabilities in both MRS and MRI not only through greater sensitivity and higher spatial resolution but by allowing the application and testing of new spectroscopic techniques and imaging sequences. The system would facilitate us in making a continuing contribution to biomedicine.